| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.800 | 25.349 | 33.931 | 46.008 | 60.915 | 56.055 | 59.512 | 59.814 | 59.226 | 58.903 |
| Total Income - EUR | 1.800 | 25.349 | 33.997 | 46.008 | 60.915 | 56.179 | 59.512 | 59.954 | 59.226 | 58.926 |
| Total Expenses - EUR | 2.359 | 10.688 | 7.839 | 14.500 | 22.650 | 17.386 | 19.337 | 22.623 | 29.663 | 26.220 |
| Gross Profit/Loss - EUR | -559 | 14.662 | 26.158 | 31.509 | 38.266 | 38.793 | 40.175 | 37.331 | 29.563 | 32.706 |
| Net Profit/Loss - EUR | -613 | 13.901 | 25.138 | 30.129 | 36.438 | 37.112 | 38.604 | 35.747 | 28.982 | 32.129 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Micri Biolife Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 1.300 | 639 | 0 | 35.783 | 27.304 | 25.560 | 13.713 | 4.713 | 584 |
| Current Assets | 760 | 12.260 | 25.415 | 33.875 | 24.774 | 30.659 | 31.289 | 10.766 | 30.376 | 33.548 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 675 | 0 | 547 | 0 | 0 | 0 | 8 | 0 | 24.260 | 25.378 |
| Cash | 85 | 12.260 | 24.867 | 33.875 | 24.774 | 30.659 | 31.281 | 10.766 | 6.116 | 8.169 |
| Shareholders Funds | -568 | 2.205 | 3.313 | 3.296 | 39.670 | 48.121 | 50.282 | 2.640 | 29.189 | 32.205 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.328 | 11.354 | 22.740 | 30.578 | 20.887 | 9.842 | 6.568 | 21.839 | 5.900 | 2.019 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Micri Biolife Srl